SCHEMBL15427199

SCHEMBL15427199

CN1CCCC2(C1)SC(=O)CN2C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12621813 0.85 CRHBP (0.30)
SCHEMBL20362782 0.81
SCHEMBL15381270 0.81 USP2 (0.31)
SCHEMBL16749609 0.81 NEK2 (0.32)
SCHEMBL21325142 0.77
SCHEMBL12621790 0.74 GRIN2D (0.35)
SCHEMBL17787253 0.70
SCHEMBL20989932 0.68
SCHEMBL15434388 0.67
SCHEMBL15381273 0.63 USP2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10363239-B2 Method for inhibiting growth of cancer cells PAIN THERAPEUTICS (US) 2019-07-30 US disclosed
US-9500640-B2 Alzheimer's disease assay in a living patient PAIN THERAPEUTICS, INC. (US) 2016-11-22 US disclosed
US-20140017699-A1 ALZHEIMER'S DISEASE ASSAY IN A LIVING PATIENT CASSAVA SCIENCES, INC. 2014-01-16 US disclosed